News Quipt Announces Multi-State Acquisition Adding Approximately $9 Million in Annualized Revenues, and Anticipated $2 Million in Adjusted EBITDA Post Integration Staff September 11, 2023 Post Navigation Previous Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in BostonNext Ardelyx Showcased Encouraging Data on Treatment Satisfaction and Efficacy of IBSRELA® (tenapanor) for IBS-C at GHAPP 2023 More Stories Clinical Trial News Pharmaceutical Vaccine ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay Staff December 23, 2024 Clinical Trial News Pharmaceutical Vaccine ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay Staff December 23, 2024 EHR Healthcare News Patient Care Hallmark Adds Senior Executives to Enhance Customer Success and Strategic Partnerships Staff December 23, 2024
